Qbic has participated in a $32.8m funding round for EyeD, consisting of $9.4m in equity and another $23.4m in debt financing and government grants.
EyeD, a Belgium-based developer of an implant to treat glaucoma that was spun out of the University Hospital of Liège (CHU Liège), has raised a total of €28m ($32.8m) from investors including multi-university venture fund Qbic.
Qbic participated in an $9.4m equity tranche together with Fund+ and assorted private investors. The remaining $23.4m came in the form of bank loans and grant financing from the Walloon government, though further details were not disclosed.
Founded in 2012, EyeD has…
